For the first time in a decade, total R&D funding in the US is forecast to drop, but the decline is expected to prompt more international collaborations and research with dual benefits.
The Norwegian Government is weighing a Euro 300M rescue package for the biotech industry as part of a national financial rescue package it is due to announce by the end of January.
The tightening financial scene presents fresh perils for start-ups. Experts gathered together by the a UK regional biotech initiative suggest some coping strategies, Nuala Moran discovers.